Aleor Derma gets USFDA nod for Clobetasol Propionate Foam Ruchika Sharma25 April 2022 3:02 PM ISTClobetasol Propionate foam is a corticosteroid indicated for treatment of moderate to severe plaque psoriasis of the scalp.
Expanded use of Amgen psoriasis drug Otezla gets USFDA okay Ruchika Sharma21 Dec 2021 11:00 AM ISTThousand Oaks: Amgen has recently announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast) for the...
Tapinarof cream beneficial for plaque psoriasis patients Dr. Nandita Mohan15 Dec 2021 11:48 AM ISTFindings from two identical phase 3 trials showed the once-daily application of tapinarof 1% cream to be superior to vehicle control in reducing...
Medical Bulletin 14/December/2021 Dr. Nandita Mohan14 Dec 2021 4:37 PM ISTHere are Top Medical news for the dayTapinarof cream effective for patients with plaque psoriasisFindings from two identical phase 3 trials showed the...
Tapinarof cream effective for patients with plaque psoriasis: Study Medha Baranwal14 Dec 2021 9:00 AM ISTUSA: Findings from two identical phase 3 trials showed the once-daily application of tapinarof 1% cream to be superior to vehicle control in reducing...
Study confirms efficacy and safety of apremilast for treatment of plaques psoriasis MD Editorial Team4 Nov 2021 9:00 AM ISTItaly: Apremilast in real-life experience confirmed the levels of safety and efficacy obtained in pivotal trials for the treatment of treat plaque...
Sun Pharma arm launches PrILUMYA to treat plaque psoriasis in Canada Ruchika Sharma28 Oct 2021 4:59 PM ISTMumbai: Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceuticals Industries Limited today announced that PrILUMYA (tildrakizumab...
Chronic plaque psoriasis tied to higher risk of lymphohematologic malignancies: Study MD Editorial Team20 Oct 2021 9:00 AM ISTItaly: The link between persistent plaque psoriasis and lymphohematologic malignancies (LHMs) is still debatable. According to a study conducted by...
Zydus Cadila arm gets USFDA nod for plaque psoriasis drug Apremilast Ruchika Sharma25 Sept 2021 12:57 PM ISTAhmedabad: Drugmaker Zydus Cadila has recently announced that the company's U. S. subsidiary Zydus Pharmaceuticals Inc. has received final approval...
Conduct phase 3 trial of plaque psoriasis FDC drug on Indian patients: CDSCO panel tells Glenmark Medical Dialogues Team22 Aug 2021 11:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Organization (CDSCO) has recommended Glenmark Pharmaceuticals...
Bimekizumab scores over adalimumab in achieving plaque psoriasis clearance: NEJM Medha Baranwal28 April 2021 10:50 AM ISTUK: Bimekizumab was shown to be noninferior and superior to adalimumab in reducing signs and symptoms of plaque psoriasis in a 56-week trial. However,...
Unichem Labs plaque psoriasis drug Apremilast gets USFDA nod Ruchika Sharma19 Feb 2021 2:00 PM ISTMumbai: Unichem Laboratories Limited, today announced that the company has received abbreviated new drug application (ANDA) approval for its...
